These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21210060)

  • 1. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of metallothionein induction combats Aß and α-synuclein toxicity in aged transgenic Caenorhabditis elegans.
    Pretsch D; Rollinger JM; Schmid A; Genov M; Wöhrer T; Krenn L; Moloney M; Kasture A; Hummel T; Pretsch A
    Sci Rep; 2020 Jul; 10(1):11707. PubMed ID: 32678125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation.
    Caldero-Escudero E; Romero-Sanz S; De la Fuente S
    Methods Cell Biol; 2024; 188():1-34. PubMed ID: 38880519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets.
    Vistbakka J; VanDuyn N; Wong G; Nass R
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):957-64. PubMed ID: 23244419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases.
    Rani N; Alam MM; Jamal A; Bin Ghaffar U; Parvez S
    Ageing Res Rev; 2023 Nov; 91():102036. PubMed ID: 37598759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Understanding Neurodegenerative Diseases: Insights from
    Wu Y; Chen Y; Yu X; Zhang M; Li Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling Parkinson's Disease in
    Ma L; Li X; Liu C; Yan W; Ma J; Petersen RB; Peng A; Huang K
    Curr Pharm Des; 2022; 28(37):3033-3048. PubMed ID: 36111767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
    Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
    Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.
    Chandler RJ; Cogo S; Lewis PA; Kevei E
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34397087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics in animal models of Alzheimer's and Parkinson's diseases.
    Sowell RA; Owen JB; Butterfield DA
    Ageing Res Rev; 2009 Jan; 8(1):1-17. PubMed ID: 18703168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epigenetics in Alzheimer's and Parkinson's disease.
    Kwok JB
    Epigenomics; 2010 Oct; 2(5):671-82. PubMed ID: 22122050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
    Wei CC; Chang CH; Liao VH
    Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
    Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
    Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease-related pathology via autophagy induction.
    Long T; Chen X; Qin DL; Zhu YF; Zhou YJ; He YN; Fu HJ; Tang Y; Yu L; Huang FH; Wang L; Yu CL; Law BY; Wu JM; Wu AG; Zhou XG
    Phytother Res; 2023 Oct; 37(10):4639-4654. PubMed ID: 37394882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.